ArticleHeliyon2024

Novel ultrasensitive automated kinetic exclusion assay for measurement of plasma levels of soluble PD-L1, the predictive and prognostic biomarker in cancer patients treated with immune checkpoint inhibitors.

Ibrahim A Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.